Cargando…
Clozapine Toxicity in the Setting of COVID-19
Autores principales: | Dotson, Samuel, Hartvigsen, Nathan, Wesner, Tara, Carbary, Timothy J., Fricchione, Gregory, Freudenreich, Oliver |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Consultation-Liaison Psychiatry. Published by Elsevier Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7260496/ https://www.ncbi.nlm.nih.gov/pubmed/32593477 http://dx.doi.org/10.1016/j.psym.2020.05.025 |
Ejemplares similares
-
Telephonic monitoring of patients on clozapine in the resource-poor setting during the COVID-19 pandemic
por: Grover, Sandeep, et al.
Publicado: (2020) -
Clozapine prescribing and safety during COVID-19
por: Wadoo, Ovais, et al.
Publicado: (2021) -
Clozapine toxicity and coronavirus disease 2019: A case report
por: Sagué-Vilavella, Maria, et al.
Publicado: (2022) -
A Covid-19 outbreak in a Spanish long-term psychiatric hospital led to infections in 6 clozapine patients: elevations in their plasma clozapine levels
por: Arrojo-Romero, Manuel, et al.
Publicado: (2022) -
A Covid-19 outbreak in a Spanish long-term psychiatric hospital led to infections in 6 clozapine patients: elevations in their plasma clozapine levels
por: Arrojo-Romero, Manuel, et al.
Publicado: (2022)